Investors

News

The Company has submitted a request for approval to conduct Phase I & II Human Trials  of its Encapsulated Islet Therapy for Type1 diabetic patients.

Keep up to date -
Sign up for email updates.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Navigation
HomeOur ScienceContactPrivacy policyTerms of Service
Contact

XOStem, Inc.
18218 McDurmott E., Suite A-1
Irvine, CA 92614

XOStem Biosciences, LTD
Suite 704, 595 Howe Street
Vancouver, BC V6C 2T5